D Alan Anthoney

5PUBLICATIONS
71CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 09, 2025
A Phase I Clinical Trial of Intrahepatic Artery Delivery of TG6002 in Combination with Oral 5-Fluorocytosine in Patients with Liver-Dominant Metastatic Colorectal Cancer.

Emma J West, Alain Sadoun, Kaidre Bendjama

|Nov 15, 2022
A Phase I/II Trial of Oral SRA737 (a Chk1 Inhibitor) Given in Combination with Low-Dose Gemcitabine in Patients with Advanced Cancer.

Robert Jones, Ruth Plummer, Victor Moreno

|Mar 22, 2022
Long-Term Outcomes and Exploratory Analyses of the Randomized Phase III BILCAP Study.

John Bridgewater, Peter Fletcher, Daniel H Palmer

|Oct 14, 2021
Pancreaticobiliary Malignancies in the Emergency Room: Management of Acute Complications and Oncological Emergencies.

Konstantinos Kamposioras, Joe Geraghty, Jordan Appleyard

|Jan 05, 2018
Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade.

Adel Samson, Karen J Scott, David Taggart

Pageof 1